WHO ICTRP trial
A Study in advanced squamous non small cell lung cancer
EUCTR2012-003214-13-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-003214-13-DE |
|---|---|
| Public title | A Study in advanced squamous non small cell lung cancer |
| Scientific title | A Randomized, Multicenter, Open-Label, Phase 2 Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Paclitaxel-Carboplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) |
| Primary sponsor | Eli Lilly and Company |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Mexico;Russian Federation;Germany;Korea, Republic of |
| Conditions | Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) MedDRA version: 16.1 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl… |
| Interventions | Product Name: Necitumumab Pharmaceutical Form: Infusion CAS Number: 906805-06-9 Other descriptive name: NECITUMUMAB Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 16- Product Name… |
| Registration date | Nov 20, 2012 |
| Target size | 189 |
| Secondary IDs | I4X-MC-JFCL |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: